RankAlpha logo
Back to Rankings

RGC

Regencell BioscienceD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
RGC vs peer average
23/100
RGC vs. peer average (D vs. B)
Grade spread
A 5 · B 2 · D 1 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

BEAM is the first available peer comparator.

Same-sector, similar-market-cap candidate from the packet; operating and indication comparability with RGC is not established, so this is only a broad biotech risk-appetite reference.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerBEAMBeam Therapeutics
RGC
Regencell Bioscience
BEAM
Beam Therapeutics
Grade
D
A
Momentum
1
18
Value
49
41
Sentiment
53
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs BEAM

RGC / BEAM
Grade Position
Below peers
RGC vs. peer average (D vs. B)
23/100
Momentum
1
BEAM
Value
49
RGC
Sentiment
53
BEAM

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RGC
1
BEAM
BEAM
A
100/100
-3
2
IMNM
IMNM
A
100/100
-3
3
TRVI
Trevi Therapeutics Inc Common
F
20/100
+1
4
SLS
SELLAS Life Sciences Group Inc Common
B
80/100
-2
5
ATAI
AtaiBeckley Inc Common
F
20/100
+1
BEAM is the first peer returned for this comparison set.